The 12 closest competitors and alternatives to TYRA among biotechnology companies — ranked by similarity to what TYRA actually does, not by market-cap band.
Subscribe to see TYRA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Tyra Biosciences is a biotechnology company headquartered in Carlsbad, California, that develops next-generation precision medicines.
TYRA is a biotechnology company headquartered in United States. It has raised at least $156M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $106M in March 2021. Xcout tracks 13 named people at TYRA, including Bhavesh Ashar (Chief Operating Officer).
7 more named people on record for TYRA, with roles, board committees and tenure — see the full roster →
At least $156M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $106M | 9 named | |
| — | $50M | 9 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to TYRA by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Mirador Therapeutics, Inc. is a clinical-stage precision medicine company headquartered in San Diego, California, focused on developing first- and best-in-class next-generation therapeutics.
Similar biotechnology company
One Biosciences is a biotechnology company headquartered in Paris, France. It is driven by innovative scientists and biotech leaders focused on advancing precision medicine and novel therapies for patients.
Biotech
Frontier Medicines, Corp. is a precision medicine company focusing on drug development with offices in locations including South San Francisco, California, and Boston.
Similar biotechnology company
KiraGen Bio is a Boston-based biotechnology company pioneering the development of AI-driven, multiplex gene-edited CAR-T cell therapies designed to target and block tumor suppression.
Life Sciences
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Similar biotechnology company
Neuron23 is a biotechnology company founded in 2018 that focuses on developing precision therapeutics for genetic diseases. Headquartered in South San Francisco, California, the company relies on a team of scientific experts and entrepreneurs.
Similar biotechnology company
BreezeBio is a biotechnology company headquartered in the South San Francisco area of California that develops precision genetic medicines.
Biotech
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Similar biotechnology company
Core Biomedicine is a preclinical-stage biotechnology and pharmaceutical manufacturing company pioneering lineage-based precision oncology therapeutics.
Biotech
Volastra Therapeutics, Inc. is a U.S. biotechnology company developing cancer medicines designed to prevent or treat metastasis, the spread of tumors to other parts of the body. It uses functional genomics and related technologies to discover therapeutic targets and serves the oncology and biopharmaceutical markets.
Similar biotechnology company
HAYA Therapeutics is a precision medicines company developing RNA-guided therapeutics to target regulatory genomic dark matter for serious diseases. The company maintains dual roots with headquarters in Lausanne, Switzerland and a U.S. location in San Diego, California. It operates as a privately held biotech innovator.
Life Sciences
Iris Medicine is an early-stage life sciences and biotechnology company pioneering allele-selective RNA therapies. Headquartered in California, the company develops novel treatments utilizing its proprietary sbRNA technology platform.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for TYRAand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →